Direkt zum Inhalt
Merck
  • Genomic alterations and evolution of cell clusters in metastatic invasive micropapillary carcinoma of the breast.

Genomic alterations and evolution of cell clusters in metastatic invasive micropapillary carcinoma of the breast.

Nature communications (2022-01-12)
Qianqian Shi, Kang Shao, Hongqin Jia, Boyang Cao, Weidong Li, Shichen Dong, Jian Liu, Kailiang Wu, Meng Liu, Fangfang Liu, Hanlin Zhou, Jianke Lv, Feng Gu, Luyuan Li, Shida Zhu, Shuai Li, Guibo Li, Li Fu
ZUSAMMENFASSUNG

Invasive micropapillary carcinoma (IMPC) has very high rates of lymphovascular invasion and lymph node metastasis and has been reported in several organs. However, the genomic mechanisms underlying its metastasis are unclear. Here, we perform whole-genome sequencing of tumor cell clusters from primary IMPC and paired axillary lymph node metastases. Cell clusters in multiple lymph node foci arise from a single subclone of the primary tumor. We find evidence that the monoclonal metastatic ancestor in primary IMPC shares high frequency copy-number loss of PRDM16 and IGSF9 and the copy number gain of ALDH2. Immunohistochemistry analysis further shows that low expression of IGSF9 and PRDM16 and high expression of ALDH2 are associated with lymph node metastasis and poor survival of patients with IMPC. We expect these genomic and evolutionary profiles to contribute to the accurate diagnosis of IMPC.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
GenomePlex® Kit zur Gesamtgenom-Amplifikation von Einzelzellen, Amplify genome of a single cell
Sigma-Aldrich
Anti-IGSF9 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution